Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Real-world data on the minimed 780G advanced hybrid closed-loop system use during type 1 diabetes pregnancy : one centre observational study
Authors:ID Munda, Ana (Author)
ID Kovacic, Chiara (Author)
ID Pongrac Barlovič, Draženka (Author)
Files:.pdf PDF - Presentation file, download (822,80 KB)
MD5: A0B837434E99FDA037C794FF7E59A763
 
URL URL - Source URL, visit https://www.sciencedirect.com/science/article/pii/S1056872724001211
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Aim The efficacy of hybrid closed-loop systems (HCLs) in managing glycemic control in pregnant women with type 1 diabetes remains inadequately characterized. We evaluated the use of the Medtronic Minimed 780G HCLs. Methods: The retrospective observational study analyzed the glycemic and perinatal outcomes of pregnant women using the HCLs, followed at our tertiary centre. Independent t-tests were employed to compare data among trimesters based on pre-pregnancy HbA1c. The associations between glycemic parameters and perinatal outcomes were explored using Spearman rho. Results: Among the 21 women (age: 33.5 ± 4.2 years, diabetes duration: 21.2 ± 7.6 years, pre-pregnancy HbA1c 7.0 ± 1.1 % (52.9 ± 11.9 mmol/mol)) time in range (pTIR, 63–140 mg/dl; 3.5–7.8 mmol/l) increased progressively throughout pregnancy (trimesters: first: 64.0 ± 9.0 %; second:71.3 ± 11.8 %; third: 75.7 ± 8.1 %). Simultaneously, mean sensor glucose decreased (trimesters: first: 130 ± 10.4 mg/dl (7.2 ± 0.6 mmol/l); second: 120.9 ± 13.4 mg/dl (6.7 ± 0.7 mmol/l); third: 117.3 ± 9.1 mg/dl (6.5 ± 0.5 mmol/l)). Although a majority of women achieved the target pTIR until the third trimester, this did not consistently prevent the delivery of a largefor-gestational-age baby. Notably, one ketoacidosis event occurred, and there were no reported instances of severe hypoglycemia. Conclusion: Use of the Minimed 780G HCLs enabled the attainment of recommended pregnancy glycemic targets for most women with type 1 diabetes in a real-world setting.
Keywords:Type 1 diabetes, pregnancy continuous glucose monitoring, closed-loop insulin delivery
Publication status:Published
Publication version:Version of Record
Year of publishing:2024
Number of pages:str. 1-7
Numbering:Vol. 38, iss. 8, [article no.] 108795
PID:20.500.12556/DiRROS-30020 New window
UDC:616.379
ISSN on article:1873-460X
DOI:10.1016/j.jdiacomp.2024.108795 New window
COBISS.SI-ID:200991491 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 8. 7. 2024;
Publication date in DiRROS:11.06.2026
Views:132
Downloads:135
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Journal of diabetes and its complications
Publisher:Elsevier Science
ISSN:1873-460X
COBISS.SI-ID:23137285 New window

Document is financed by a project

Funder:Other - Other funder or multiple funders
Funding programme:Univerzitetni klinični center Ljubljana
Project number:20220126
Name:Biokemijski in citokinski označevalci iz sline pri obravnavi žensk z nosečnostno sladkorno boleznijo

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Back